https://c19early.org/chxmeta.html
Chlorhexidine reduces COVID-19 risk: real-time meta-analysis of 5 studies
5 chlorhexidine COVID-19 controlled studies. 69% improvement for early treatment, p = 0.00063.
risk real timereduces covidmeta analysischlorhexidinestudies
https://c19early.org/ptmeta.html
Phthalocyanine reduces COVID-19 risk: real-time meta-analysis of 4 studies
4 phthalocyanine COVID-19 controlled studies. 38% improvement, p = 0.00019.
risk real timereduces covidmeta analysisstudies
https://c19early.org/ncmeta.html
Niclosamide reduces COVID-19 risk: real-time meta-analysis of 7 studies
7 niclosamide COVID-19 controlled studies. 29% improvement for early treatment, p = 0.0077.
risk real timereduces covidmeta analysisniclosamidestudies
https://c19early.org/fmmeta.html
Famotidine reduces COVID-19 risk: real-time meta-analysis of 29 studies
29 famotidine COVID-19 controlled studies. 16% improvement, p = 0.00072.
risk real timereduces covidmeta analysisstudies
https://c19early.org/iufhmeta.html
Inhaled Heparin reduces COVID-19 risk: real-time meta-analysis of 3 studies
3 inhaled heparin COVID-19 controlled studies. 50% improvement, p = 0.0077.
risk real timereduces covidmeta analysisinhaledheparin
https://c19early.org/nometa.html
Nitric Oxide reduces COVID-19 risk: real-time meta-analysis of 14 studies
14 nitric oxide COVID-19 controlled studies. 44% improvement for early treatment, p = 0.0097.
risk real timenitric oxidereduces covidmeta analysisstudies
https://c19early.org/hmeta.html
Hydroxychloroquine reduces COVID-19 risk: real-time meta-analysis of 423 studies (c19hcq hcqmeta)
risk real timereduces covidmeta analysishydroxychloroquinestudies
https://c19early.org/zmeta.html
Zinc reduces COVID-19 risk: real-time meta-analysis of 41 studies
41 zinc COVID-19 controlled studies. 41% improvement for early treatment, p = 0.018.
risk real timereduces covidmeta analysiszincstudies
https://c19early.org/jmeta.html
Melatonin reduces COVID-19 risk: real-time meta-analysis of 18 studies
risk real timereduces covidmeta analysismelatoninstudies
https://c19early.org/spmeta.html
Spironolactone reduces COVID-19 risk: real-time meta-analysis of 12 studies
12 spironolactone COVID-19 controlled studies. 31% improvement, p = 0.00046.
risk real timereduces covidmeta analysisstudies
https://c19early.org/azvmeta.html
Azvudine reduces COVID-19 risk: real-time meta-analysis of 42 studies
42 azvudine COVID-19 controlled studies. 32% improvement for early treatment, p = 0.032.
risk real timereduces covidmeta analysisstudies
https://c19early.org/mfmeta.html
Metformin reduces COVID-19 risk: real-time meta-analysis of 111 studies
risk real timereduces covidmeta analysismetforminstudies
https://c19early.org/nacmeta.html
N-acetylcysteine reduces COVID-19 risk: real-time meta-analysis of 25 studies
risk real timereduces covidmeta analysisstudies
https://c19early.org/phmeta.html
Alkalinization reduces COVID-19 risk: real-time meta-analysis of 14 studies
risk real timereduces covidmeta analysisstudies
https://c19early.org/cpmmeta.html
Chlorpheniramine reduces COVID-19 risk: real-time meta-analysis of 3 studies
risk real timereduces covidmeta analysisstudies
https://c19early.org/ttmeta.html
Thermotherapy reduces COVID-19 risk: real-time meta-analysis of 4 studies
4 thermotherapy COVID-19 controlled studies. 56% improvement, p = 0.026.
risk real timereduces covidmeta analysisstudies
https://c19early.org/slmeta.html
Improved sleep reduces COVID-19 risk: real-time meta-analysis of 16 studies
risk real timereduces covidmeta analysisimprovedsleep
https://c19early.org/qmeta.html
Quercetin reduces COVID-19 risk: real-time meta-analysis of 9 studies
9 quercetin COVID-19 controlled studies. 32% improvement for early treatment, p = 0.014.
risk real timereduces covidmeta analysisquercetinstudies
https://c19early.org/umeta.html
Budesonide reduces COVID-19 risk: real-time meta-analysis of 15 studies
risk real timereduces covidmeta analysisbudesonidestudies
https://c19early.org/tmeta.html
Curcumin reduces COVID-19 risk: real-time meta-analysis of 28 studies
28 curcumin COVID-19 controlled studies. 29% improvement for early treatment, p = 0.0014.
risk real timereduces covidmeta analysiscurcuminstudies
https://c19early.org/pmeta.html
Povidone-Iodine reduces COVID-19 risk: real-time meta-analysis of 21 studies
risk real timereduces covidmeta analysispovidoneiodine
https://c19early.org/imeta.html
Ivermectin reduces COVID-19 risk: real-time meta-analysis of 106 studies (c19ivm ivmmeta)
risk real timereduces covidmeta analysisivermectinstudies
https://c19early.org/naclmeta.html
NaCl reduces COVID-19 risk: real-time meta-analysis of 9 studies
9 NaCl COVID-19 controlled studies. 23% improvement, p = 0.0028.
risk real timereduces covidmeta analysisnaclstudies
https://c19early.org/cmeta.html
Vitamin C reduces COVID-19 risk: real-time meta-analysis of 72 studies
72 vitamin C COVID-19 controlled studies. 34% improvement for early treatment, p = 0.0082.
risk real timereduces covidmeta analysisvitaminstudies
https://c19early.org/yu.html
Yu: Low Dose of Hydroxychloroquine Reduces Fatality of Critically Ill Patients With COVID-19 [HCQ]
Yu, 550 patient HCQ late treatment study: 60% lower mortality (p=0.002). Retrospective, 550 critically ill patients. 19% fatality for HCQ versus 47% for non.....
low dosecritically illyuhydroxychloroquinereduces
https://marksking.com/my-fabulous-disease/uscha-goes-virtual-again/
For a Second Year, COVID Reduces USCHA to a Virtual Event - My Fabulous Disease
A shortened, virtual event will take place December 2-3, 2021.
second yearvirtual eventcovidreducesfabulous